Insider · CIK 0001724058

Hunt Daniel W.

Reports to the SEC for 1 company · BURLINGAME, CA

Transactions

Companies

Filings

CIK

0001724058

Forms 4 and 5

Insider transactions

3 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Business Officer	AAward	+75K sh	—	—	75,000
2018-12-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Business Officer	AAward	−50K sh	—	—	50,000
2017-12-13	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	SVP, Chief Business Officer	AAward	+200K sh	—	—	200,000

C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102

BURLINGAME, CA, 94010